Idexx Laboratories (IDXX) Stock Price, Quote & News

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test ki...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 207 556 0300

Fax: 207 556 4346

Website: www.idexx.com

Address:

One IDEXX Drive, Westbrook, United States

MyChicago Feb. 25 at 4:19 PM

$ZOMDF $IDXX. New partner and distribution contracts with Moichor for ZOMEDICA announced today. CEO was also with IDXX for many years. Great New. BULLISH.

0 · Reply

MyChicago Feb. 25 at 4:11 PM

$ZOMDF $IDXX CEO of Moichor. Also was with IDXX for many years. Great fit for Zomedic. https://rocketreach.co/joseph-faiella-email_6078647

0 · Reply

MyChicago Feb. 25 at 2:39 PM

$ZOMDF $IDXX New Distribution deal with Moichor. Possibility for ZOMDF to manufacture also. Just a thought. distribution deals sometimes evolve into deeper supply arrangements (OEM, private‑labeling, or contract manufacturing) if both parties agree to scale production, share tooling, or consolidate supply chains. If Zomedica already has manufacturing capacity for similar devices — a company that already manufactures related hardware could be a logical partner to produce co‑branded units

1 · Reply

MyChicago Feb. 25 at 2:11 PM

$ZOMDF $IDXX

1 · Reply

MyChicago Feb. 25 at 2:07 PM

$ZOMDF Expands National Distribution with Moichor : CEO Of Moichor. 13 Years at $IDXX

1 · Reply

Wisenheimer Feb. 25 at 1:33 PM

$ZOMDF hmmmm Moicher CEO previously spent 13yrs at $IDXX

2 · Reply

TechniTraderEducation Feb. 24 at 5:44 PM

$IDXX Volatility ≠ chaos. If you know the signals, it’s opportunity. Full chart breakdown on TradingView: https://www.tradingview.com/chart/IDXX/Kho1I5hx-Solve-The-Problem-pf-Trading-in-a-Volatile-Market/ #Stocks #SwingTrading #MarketStructure #VolatilityTrading

0 · Reply

Sashko2018 Feb. 24 at 1:47 PM

$IDXX

0 · Reply

RumbleTrump Feb. 23 at 10:20 PM

$AIDX look at $IDXX If AIDX works out we could be millionaire

0 · Reply

RiskOverseer Feb. 18 at 4:47 PM

$IDXX IDEXX Laboratories provides diagnostics for animal health. Recurring revenue and pricing power support valuation. Growth is steady and defensive.

0 · Reply

Baron Partners Fund Q4 2025 Contributors And Detractors

CSGP GWRE H IT MTN SPOT TSLA

Feb 12, 2026, 4:15 PM EST - 13 days ago

IDEXX Laboratories to Present at Two Institutional Investor Conferences

Feb 3, 2026, 10:12 AM EST - 22 days ago

IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results

Feb 2, 2026, 11:40 AM EST - 23 days ago

IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript

Feb 2, 2026, 8:12 AM EST - 23 days ago

IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics

Feb 2, 2026, 6:30 AM EST - 23 days ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

Jan 25, 2026, 10:09 AM EST - 4 weeks ago

Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards

BSY CSGP GNRC JKHY POOL RGEN ROL

Jan 15, 2026, 12:30 PM EST - 5 weeks ago

MoneyShow's Best Investment Ideas For 2026: Part 5

HRL HUT IONQ KDK MNKD

Jan 15, 2026, 7:15 AM EST - 5 weeks ago

Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus

Jan 15, 2026, 7:00 AM EST - 5 weeks ago

IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs

Jan 13, 2026, 8:30 AM EST - 6 weeks ago

IDEXX Announces CEO Succession

Jan 9, 2026, 1:30 PM EST - 6 weeks ago

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

Jan 7, 2026, 1:51 PM EST - 7 weeks ago

Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB

COF PANW XLB

Nov 24, 2025, 2:15 PM EST - 3 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

RMD

Nov 13, 2025, 2:30 AM EST - 3 months ago

Baron Asset Fund Q3 2025 Performance Review

APH CHH FDS IT MORN ONON STUB

Nov 4, 2025, 5:31 AM EST - 4 months ago

IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects

Nov 3, 2025, 1:29 PM EST - 4 months ago

Final Trades: Meta, S&P Global and Idexx Lab

META SPGI

Nov 3, 2025, 11:36 AM EST - 4 months ago

IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 11:08 AM EST - 4 months ago

Idexx Stock Pops on Earnings. Pet Health Is Booming.

Nov 3, 2025, 10:55 AM EST - 4 months ago

Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook

Nov 3, 2025, 7:43 AM EST - 4 months ago

IDEXX raises annual forecasts as pet owners spend more on preventive care

Nov 3, 2025, 6:30 AM EST - 4 months ago

IDEXX Laboratories Announces Third Quarter Results

Nov 3, 2025, 1:01 AM EST - 4 months ago

IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Oct 8, 2025, 2:00 PM EDT - 5 months ago

IDEXX Laboratories to Release 2025 Third Quarter Financial Results

Oct 7, 2025, 7:00 AM EDT - 5 months ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors

Sep 9, 2025, 5:24 PM EDT - 6 months ago

IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 1:00 PM EDT - 6 months ago

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 7, 2025, 9:35 PM EDT - 7 months ago

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

ARGX COO ELV HQY INSM ISRG RDNT

Aug 4, 2025, 5:55 PM EDT - 7 months ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 2:37 PM EDT - 7 months ago

IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:48 PM EDT - 7 months ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Aug 4, 2025, 12:15 PM EDT - 7 months ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 10:45 AM EDT - 7 months ago

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Aug 4, 2025, 9:10 AM EDT - 7 months ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 7:57 AM EDT - 7 months ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 6:30 AM EDT - 7 months ago

IDEXX Laboratories Announces Second Quarter Results

Jul 30, 2025, 7:00 AM EDT - 7 months ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 17, 2025, 7:06 AM EDT - 7 months ago

IDEXX Laboratories: A Business With Strong Fundamentals

Jul 10, 2025, 7:00 AM EDT - 8 months ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jun 24, 2025, 1:00 PM EDT - 8 months ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 5, 2025, 7:00 AM EDT - 9 months ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

May 14, 2025, 2:35 PM EDT - 10 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 13, 2025, 2:30 PM EDT - 10 months ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 1, 2025, 10:35 AM EDT - 10 months ago

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

May 1, 2025, 8:21 AM EDT - 10 months ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

May 1, 2025, 6:30 AM EDT - 10 months ago

IDEXX Laboratories Announces First Quarter Results

Apr 3, 2025, 1:30 PM EDT - 11 months ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Mar 17, 2025, 5:40 AM EDT - 1 year ago

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'

Mar 12, 2025, 6:24 AM EDT - 1 year ago

IDEXX Laboratories: A Top Dog In The Pet Care Market

Feb 13, 2025, 2:00 PM EST - 1 year ago

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

MyChicago Feb. 25 at 4:19 PM

$ZOMDF $IDXX. New partner and distribution contracts with Moichor for ZOMEDICA announced today. CEO was also with IDXX for many years. Great New. BULLISH.

0 · Reply

MyChicago Feb. 25 at 4:11 PM

$ZOMDF $IDXX CEO of Moichor. Also was with IDXX for many years. Great fit for Zomedic. https://rocketreach.co/joseph-faiella-email_6078647

0 · Reply

MyChicago Feb. 25 at 2:39 PM

1 · Reply

MyChicago Feb. 25 at 2:11 PM

$ZOMDF $IDXX

1 · Reply

MyChicago Feb. 25 at 2:07 PM

$ZOMDF Expands National Distribution with Moichor : CEO Of Moichor. 13 Years at $IDXX

1 · Reply

Wisenheimer Feb. 25 at 1:33 PM

$ZOMDF hmmmm Moicher CEO previously spent 13yrs at $IDXX

2 · Reply

TechniTraderEducation Feb. 24 at 5:44 PM

0 · Reply

Sashko2018 Feb. 24 at 1:47 PM

$IDXX

0 · Reply

RumbleTrump Feb. 23 at 10:20 PM

$AIDX look at $IDXX If AIDX works out we could be millionaire

0 · Reply

RiskOverseer Feb. 18 at 4:47 PM

$IDXX IDEXX Laboratories provides diagnostics for animal health. Recurring revenue and pricing power support valuation. Growth is steady and defensive.

0 · Reply

OfficialStocktwitsUser Feb. 18 at 11:59 AM

$IDXX RSI: 24.57, MACD: -17.9994 Vol: 27.63, MA20: 660.30, MA50: 684.55 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZomedicaPharm Feb. 18 at 9:55 AM

$ZOMDF $IDXX

1 · Reply

MyChicago Feb. 17 at 8:15 PM

$ZOMDF $IDXX IDXX built a $50B empire on: Point‑of‑care analyzers Proprietary cartridges AI diagnostics Recurring revenue Clinic lock‑in ZOMEDICA is now in ALL the same lanes but at microcap pricing. TRUFORMA equals POC revenue AI cytology/radiology/pathology = high‑margin software VetGuardian, remote monitoring (IDXX doesn’t even have this) Cartridges ,subscriptions equals recurring revenue flywheel IDEXX is the giant. Zomedica is the undervalued version building the same ecosystem from the ground up. That’s the setup.

1 · Reply

BillionerOfKing Feb. 16 at 1:31 PM

$IDXX Current Stock Price: $628.92 Contracts to trade: $630.0 IDXX Feb 20 2026 Call Entry: $7.80 Exit: $10.58 ROI: 36% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ZomedicaPharm Feb. 11 at 2:33 PM

$ZOMDF $IDXX

1 · Reply

MyChicago Feb. 10 at 4:26 PM

$ZOMDF $IDXX IDXX is strictly a veterinary diagnostics company, not a human‑health diagnostics company. Every product line they offer is built for animals, not people. Their reference labs, SNAP tests, analyzers, imaging systems, and software are all designed for small‑animal, livestock, equine, and water testing, with no human‑diagnostic division or FDA‑regulated human products. That’s why Zomedica stepping into human diagnostics stands out so much — it’s a lane IDXX doesn’t operate in.

0 · Reply

GoldenGamma Feb. 4 at 11:29 AM

$IDXX is the veterinary diagnostics leader with a premium pricing model; practice visit trends and consumable sales are drivers.

0 · Reply

erevnon Feb. 3 at 11:40 AM

BTIG maintains IDEXX Laboratories $IDXX at Buy and lowers the price target from $830 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

EingeLTrade Feb. 2 at 10:24 PM

Today's most important earnings reports $PLTR $DIS $SPG $IDXX $TER

0 · Reply

WallStreetBuyDip Feb. 2 at 6:35 PM

not chasing $IDXX here. waiting for H% to show low like usual

0 · Reply

ZacksResearch Feb. 2 at 3:36 PM

$IDXX beats Q4 estimates, but shares dip 1.5%. What's up? 🤔 🔍 Full-year 2025 EPS up 22.6%, topping estimates by 1.2%. 📈 Quarterly revenues rose 14%, driven by 15% growth in CAG and 12% in Water segment. 💡 2026 guidance calls for 9-13% EPS growth. Detailed insights here 👉 https://www.zacks.com/stock/news/2827048/idexx-stock-down-despite-q4-earnings-revenue-beat-margins-rise?cid=sm-stocktwits-2-2827048-body-31447&ADID=SYND_STOCKTWITS_TWEET_2_2827048_BODY_31447

0 · Reply

LilySanders Feb. 2 at 3:31 PM

$IDXX steady trend intact defensive growth name watching for continuation if market stays orderly

0 · Reply

Market Cap	51.69B
Revenue (ttm)	4.30B
Net Income (ttm)	1.06B
EPS (ttm)	N/A
PE Ratio	47.68
Forward PE	42.85
Profit Margin	24.62%
Debt to Equity Ratio	0.28

Volume	504,500
Avg Vol	511,944
Day's Range	N/A - N/A
Shares Out	79.62M
Stochastic %K	90%
Beta	1.67
Analysts	Strong Sell
Price Target	$773.58